• Home
  • Reconceptualizing Risk-Benefit Assessment of Novel Cancer Therapies to Expand Global Access and Reduce Worldwide Mortality.

Reconceptualizing Risk-Benefit Assessment of Novel Cancer Therapies to Expand Global Access and Reduce Worldwide Mortality.

Author List
DeBoer RJ, Rugo HS, Shulman LN
Publication
JAMA oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/249374146
Publication Year
2022
PubMed ID
34882172
Publication Title
DeBoer RJ, Rugo HS, Shulman LN. Reconceptualizing Risk-Benefit Assessment of Novel Cancer Therapies to Expand Global Access and Reduce Worldwide Mortality. JAMA Oncol. 2022 02 01; 8(2):203-204.